Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study (2014)
- Authors:
- Autor USP: PEREIRA, JULIANA - FM
- Unidade: FM
- DOI: 10.1200/JCO.2013.52.2631
- Subjects: LINFOMA (TERAPIA); MEDICAÇÃO INTRAVENOSA; ANTINEOPLÁSICOS (ADMINISTRAÇÃO E DOSAGEM)
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Clinical Oncology
- ISSN: 0732-183X
- Volume/Número/Paginação/Ano: v. 32, n. 17, p. 1782-1791, 2014
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SALAR, Antonio et al. Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study. Journal of Clinical Oncology, v. 32, n. 17, p. 1782-1791, 2014Tradução . . Disponível em: https://doi.org/10.1200/JCO.2013.52.2631. Acesso em: 21 jan. 2026. -
APA
Salar, A., Avivi, I., Bittner, B., Bouabdallah, R., Brewster, M., Catalani, O., et al. (2014). Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study. Journal of Clinical Oncology, 32( 17), 1782-1791. doi:10.1200/JCO.2013.52.2631 -
NLM
Salar A, Avivi I, Bittner B, Bouabdallah R, Brewster M, Catalani O, Follows G, Haynes A, Hourcade-Potelleret F, Janikova A, Larouche J-F, McIntyre C, Pedersen M, Pereira J, Sayyed P. Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study [Internet]. Journal of Clinical Oncology. 2014 ; 32( 17): 1782-1791.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1200/JCO.2013.52.2631 -
Vancouver
Salar A, Avivi I, Bittner B, Bouabdallah R, Brewster M, Catalani O, Follows G, Haynes A, Hourcade-Potelleret F, Janikova A, Larouche J-F, McIntyre C, Pedersen M, Pereira J, Sayyed P. Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study [Internet]. Journal of Clinical Oncology. 2014 ; 32( 17): 1782-1791.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1200/JCO.2013.52.2631 - Expression of CysLTR1 and 2 in Maturating Lymphocytes of Hyperplasic Tonsils Compared to Peripheral Cells in Children
- Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 study
- A difficult case of angioimmunoblastic T-cell lymphoma to diagnose
- Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study
- Clinical prognostic models in diffuse large B cell lymphoma patients are still essencial in the rituximab era
- Factors associated with survival in patients with lymphoma and HIV
- Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes
- Time-to-treatment of diffuse large B-cell lymphoma in São Paulo
- GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms
- Panoramic and skull imaging may aid in the identification of multiple myeloma lesions
Informações sobre o DOI: 10.1200/JCO.2013.52.2631 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
